The clinical nutrition for diabetes care market size is expected to see strong growth in the next few years. It will grow to $4 billion in 2028 at a compound annual growth rate (CAGR) of 8.1%. The anticipated growth in the forecast period can be attributed to factors such as insurance coverage for diabetes management, healthcare expenditure, the obesity epidemic, the aging population, and the increasing prevalence of diabetes. Major trends expected in the forecast period encompass an increasing focus on immune-supportive nutrition, plant-based nutrition, functional foods and supplements, integration of digital health technologies, and the development of personalized nutrition plans.
The rise in diabetes prevalence is poised to drive the expansion of the clinical nutrition for diabetes care market in the coming years. Diabetes, characterized by elevated blood sugar levels due to insufficient insulin production or ineffective insulin utilization, is influenced by factors such as sedentary lifestyles, poor dietary choices, genetic predisposition, and aging populations. Clinical nutrition for diabetes care plays a pivotal role in aiding patients in managing their condition through tailored dietary plans that regulate blood sugar levels, facilitate weight management, and mitigate complications risk. For instance, as per the International Diabetes Federation, the global number of individuals aged 20-79 with diabetes reached 537 million in 2021, projected to escalate to 643 million by 2030 and 783 million by 2045. Consequently, the uptick in diabetes prevalence is propelling the growth of the clinical nutrition for diabetes care market.
Key players in the clinical nutrition for diabetes care sector are actively developing specialized nutritional formulations to cater to the distinct dietary requirements of diabetic patients, focusing on blood sugar level management and overall health support. These formulations offer balanced nutrition, blood sugar control, and holistic health benefits for diabetes patients. For example, in December 2021, Danone India unveiled Protinex Diabetes Care, a scientifically formulated product addressing the nutritional needs of Indian diabetes patients. Fortified with 26 essential vitamins and minerals, the product, available in vanilla flavor, boasts low fat content, no added sugar, and reduced calories, making it a nutritious option for diabetic individuals. Notably, it stands as the sole product in the powder nutrition category with a low Glycemic Index (GI) of 17, aiding in blood sugar level management.
In June 2023, Abbott Laboratories, a US-based healthcare and medical devices company specializing in specialized nutritional products, forged a partnership with the American Diabetes Association (ADA). This collaboration aims to spearhead innovative solutions for diabetes management and care by developing advanced technologies, educational materials, and support systems to empower individuals living with diabetes. The American Diabetes Association (ADA), a US-based nonprofit organization, is dedicated to raising diabetes awareness and providing resources for diabetes education.
Major companies operating in the clinical nutrition for diabetes care market are Pfizer Inc., Bayer AG, Sanofi-Aventis LLC, Abbott Laboratories, Roche Holdings Inc, Medtronic plc, Danone SA, Eli Lilly and Company, Amgen Inc., Senseonics Holdings Inc., Teva Pharmaceutical Industries Ltd, Baxter International Inc., B. Braun Melsungen AG, Glanbia plc, Perrigo Company plc, Dexcom Inc., Nestlé Health Science S.A., Tandem Diabetes Care, Nutricia International Private Limited, MannKind Corp, Omada Health, Senseonics Holdings Inc., Diasome Pharmaceuticals Inc., Zucara Therapeutics Inc, Victus Inc.
North America was the largest region in the clinical nutrition for diabetes care market in 2023. The regions covered in the clinical nutrition for diabetes care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the clinical nutrition for diabetes care market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Clinical nutrition for diabetes care involves providing specialized dietary guidance and nutritional support to individuals managing diabetes, encompassing personalized assessments, meal planning, and education on carbohydrate management, glycemic control, and lifestyle modifications. The primary objective is to optimize nutrition, regulate blood sugar levels, prevent complications, and improve overall health outcomes for those with diabetes.
The main products in the clinical nutrition for diabetes care market include oral nutrition, parenteral nutrition, and enteral feeding formulas. Oral nutrition refers to dietary supplements, drinks, or foods consumed orally to meet the nutritional needs of individuals with diabetes, aiming to effectively manage blood sugar levels. These products cater to patients at various stages of adulthood and pediatrics and are distributed through various channels including online, retail, and institutional sales.
The clinical nutrition for diabetes care market research report is one of a series of new reports that provides clinical nutrition for diabetes care market statistics, including clinical nutrition for diabetes care industry global market size, regional shares, competitors with a clinical nutrition for diabetes care market share, detailed clinical nutrition for diabetes care market segments, market trends and opportunities, and any further data you may need to thrive in the clinical nutrition for diabetes care industry. This clinical nutrition for diabetes care market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The clinical nutrition for diabetes care market consists of revenues earned by entities by providing services such as medical nutrition therapy, dietary counseling, and diabetes self-management education and support. The market value includes the value of related goods sold by the service provider or included within the service offering. The clinical nutrition for diabetes care market also includes sales of oral nutrition supplements, enteral nutrition, glucose control formulas, and low-glycemic index foods. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
Executive Summary
Clinical Nutrition For Diabetes Care Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on clinical nutrition for diabetes care market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for clinical nutrition for diabetes care? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The clinical nutrition for diabetes care market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
- The impact of higher inflation in many countries and the resulting spike in interest rates.
- The continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Product: Oral Nutrition; Parenteral Nutrition; Enteral Feeding Formulas2) By Stage: Adult; Pediatric
3) By Sales Channel: Online; Retail; Institutional Sales
Key Companies Mentioned: Pfizer Inc.; Bayer AG; Sanofi-Aventis LLC; Abbott Laboratories; Roche Holdings Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Pfizer Inc.
- Bayer AG
- Sanofi-Aventis LLC
- Abbott Laboratories
- Roche Holdings Inc
- Medtronic plc
- Danone SA
- Eli Lilly and Company
- Amgen Inc.
- Senseonics Holdings Inc.
- Teva Pharmaceutical Industries Ltd
- Baxter International Inc.
- B. Braun Melsungen AG
- Glanbia plc
- Perrigo Company plc
- Dexcom Inc.
- Nestlé Health Science S.A.
- Tandem Diabetes Care
- Nutricia International Private Limited
- MannKind Corp
- Omada Health
- Senseonics Holdings Inc.
- Diasome Pharmaceuticals Inc.
- Zucara Therapeutics Inc
- Victus Inc.
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 175 |
Published | July 2024 |
Forecast Period | 2024 - 2028 |
Estimated Market Value ( USD | $ 2.93 Billion |
Forecasted Market Value ( USD | $ 4 Billion |
Compound Annual Growth Rate | 8.1% |
Regions Covered | Global |